This collection is comprised of peer-reviewed educational articles selected by the editor and provides a wealth of information around noninvasive prenatal testing from well-respected titles in obstetrics, gynaecology and genetics.
Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing
What’s already known about this topic?
Incidental diagnoses of an occult maternal malignancy have been reported upon aberrant routine noninvasive prenatal testing (NIPT).
The presence of tumor‐derived cell‐free DNA in the maternal circulation can skew the NIPT profile.
What does this study add?
Pregnant women with a confirmed neoplastic disease should not have NIPT testing for fetal aneuploidy screening since NIPT results cannot accurately be applied to assess the fetal chromosomal constitution in this condition.
This article can be viewed on Wiley Online Library.